European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
141
Issue Information86
Issue Information73
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study65
Progress and challenges in the symbiosis of AI with science and medicine60
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants54
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’52
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review51
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease48
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis46
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study44
Issue Information43
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease41
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion41
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus41
Impact of Anaemia on Management and Outcomes in Patients With Atrial Fibrillation: Insights From European and Asian Cohorts41
Social determinants of health and cardiovascular outcomes in patients with heart failure41
Adipocyte maturation impacts daunorubicin disposition and metabolism38
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function37
Practical considerations for the use of vericiguat in older patients with heart failure and reduced ejection fraction37
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?37
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial34
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis33
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?33
Blood pressure measurement for prediction of chronic pressure overload and cardiovascular events33
Automatic reorientation algorithm for myocardial perfusion SPECT using segmentation32
Comparison between thoracic ultrasound and chest x‐ray in detection of non‐infective early complications of cardiac implantable electronic devices implantation ( CRUSADERS32
The hinge‐1 domain of Flna is not necessary for diverse physiological functions in mice32
Short‐ and long‐term risk stratification in acutely ill medical patients by implementing ankle‐brachial index and pulse wave velocity in the emergency setting31
Angiopoietin‐like protein 2 and mortality in patients with heart failure—Results from an observational study31
The glucagon‐like peptide‐1 receptor agonist semaglutide in diabetic kidney disease: A new kid on the block to afford maximal kidney protection30
0.45364999771118